David B. Wells - Dec 15, 2021 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
4
Date filed
12/17/2021, 08:27 PM
Previous filing
Aug 30, 2021
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +40.2K +11.16% 400K Dec 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -36.5K -25% $0.00 110K Dec 15, 2021 Class A Common Stock 36.5K Direct F1, F2
transaction HIMS Restricted Stock Unit Options Exercise $0 -3.57K -24.99% $0.00 10.7K Dec 15, 2021 Class A Common Stock 3.57K Direct F1, F2
transaction HIMS Restricted Stock Unit Options Exercise $0 -71 -25% $0.00 213 Dec 15, 2021 Class A Common Stock 71 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares were issued pursuant to vested RSUs released on December 15, 2021.
F2 The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2020. The remaining 75% vest in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the Company.